R&D Transforming drug development with statistical methodologies The product development lifecycle is long and challenging.
Market Access Pharmacogenomics and IVDR: Overcoming transition challenges In recent years, the in vitro diagnostics (IVD) regulatory landscape in Europe has changed and we are now in the transition from IVD Directive 98/79/EC (IVDD) to In Vitro
R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
